Accord Healthcare, Inc. is recalling 502 cartons of Glycopyrrolate Injection, USP (0.4 mg/2 mL). The recall was initiated because 2 mL vials were incorrectly packaged into blister strips labeled for 1 mL vials, even though the individual vials inside are correctly labeled. Consumers should contact their healthcare provider or pharmacist regarding this medication, as the labeling error could lead to confusion about the volume of the dose being administered.
The packaging mix-up involves 2 mL vials placed in 1 mL blister strips, which may cause a healthcare provider to misinterpret the dosage or volume of the medication. This poses a risk of dosing errors during administration.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.